Report Content
Chapter 1 Methodology & Scope
1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 COVID-19 Impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Coronary stents industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Coronary Stents Industry Insights
3.1 Industry segmentation
3.2 Industry landscape
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising burden of coronary artery disease
3.3.1.2 Increasing demand for minimally invasive procedures
3.3.1.3 Technological advancement in developing economies
3.3.1.4 Growing geriatric population
3.3.2 Industry pitfalls & challenges
3.3.2.1 Product failure and recall
3.3.2.2 Stringent regulatory approvals
3.3.2.3 Dearth of skilled healthcare professional in developing economies
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Company positioning matrix
4.4 Strategic dashboard
Chapter 5 Coronary Stents Market, By Product
5.1 Key product trends
5.2 Drug eluting stent
5.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 – 2032 (000’ Units)
5.3 Bare metal stent
5.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 – 2032 (000’ Units)
5.4 Bioresorbable vascular scaffold (BVS)
5.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 – 2032 (000’ Units)
Chapter 6 Coronary Stents Market, By End-use
6.1 Key end-use trends
6.2 Hospitals
6.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.3 Cardiac centers
6.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.4 Ambulatory surgical centers
6.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2018 – 2032 (USD Million)
Chapter 7 Coronary Stents Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Switzerland
7.3.8 Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 South Korea
7.4.5 Indonesia
7.4.6 Thailand
7.4.7 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Chile
7.5.5 Colombia
7.5.6 Peru
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Egypt
7.6.5 Israel
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 B. Braun Melsungen AG
8.3 Biosensors International Group
8.4 Biotronik SE & Co. KG
8.5 Boston Scientific Corporation
8.6 Elixir Medical Corporation
8.7 Medtronic Plc.
8.8 Meril Life Science
8.9 MicroPort Scientific Corporation
8.10 Terumo Corporation
